Nuburu(US:BURU)2026-03-31 21:10Financial Performance - For the year ended December 31, 2025, the company incurred a net loss of $79,071,276, compared to a net loss of $34,515,754 for 2024, resulting in an accumulated deficit of $200,479,831 as of December 31, 2025[252]. - The company generated total revenue of nil for the year ended December 31, 2025, down from $152,127 in 2024[252]. - The company reported a net loss of $79,071,276 in 2025, an increase of $44,555,522 from the net loss of $34,515,754 in 2024[309]. - Loss from operations was $18,376,593 in 2025, compared to a loss of $13,150,890 in 2024, indicating a worsening operational performance[309]. - The net cash used in operating activities increased to $16,090,302 in 2025 from $6,616,941 in 2024, primarily due to a net loss increase of $44,555,522[346]. - The company anticipates continuing to incur net losses for the foreseeable future and is pursuing a Transformation Plan to improve its financial condition[340]. Cost Management - The company has initiated cost-reduction measures, including employee furloughs, due to insufficient funding, which led to the resignation of several key employees[253]. - Cost of revenue decreased by $2,024,103 in 2025, attributed to a reduction in direct labor and overhead costs due to decreased production[310]. - Research and development expenses decreased by $1,647,257 in 2025, mainly due to personnel cost reductions and furloughs of R&D employees[311]. - General and administrative expenses rose to $13,348,686 in 2025, an increase of $4,541,035 from 2024, driven by scaling headcount and compliance costs[287]. - Selling and marketing expenses increased significantly to $4,671,975 in 2025, up from $468,074 in 2024, reflecting expansion efforts[309]. Financing Activities - The company plans to finance its operations through the issuance and sale of debt or equity securities, including a Standby Equity Purchase Agreement allowing for the sale of up to $100,000,000 of Common Stock[265]. - On December 17, 2025, the company completed a $25,000,000 financing transaction, resulting in gross cash proceeds of $23,250,000 after a 7.0% original issue discount[262]. - The company generated $58,133,746 from financing activities in 2025, a substantial increase from $4,677,578 in 2024, primarily from debt instruments and the SEPA[349][350]. - Gross cash proceeds of $30,406,708 were received from certain debt instruments issued during 2025[338]. Compliance and Regulatory Issues - The company received a Notice of Noncompliance from NYSE Regulation on April 29, 2025, due to not maintaining stockholders' equity of $2,000,000 or more[276]. - A 1-for-4.99 reverse stock split was executed on February 27, 2026, to comply with NYSE American's Minimum Trading Price requirement[251][273]. Asset Management - The company wrote down its inventory and property to a net realizable value of zero during the first quarter of 2025 due to lease defaults[275]. - The company has recorded a full valuation allowance against its deferred tax assets due to historical net losses, which may change based on future operating results[368]. Future Outlook - The company has not yet achieved commercialization and expects to incur significant expenses and operating losses for the foreseeable future[254]. - Future liquidity may be provided from agreements executed after December 31, 2025, as detailed in the financial statements[338]. - The company has yet to generate meaningful revenue from operations and relies on debt and equity financing for capital expenditures and working capital[338].